Text Size
107 studies found for:    Open Studies | "Hypercholesterolemia"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hypercholesterolemia"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Efficacy and Safety of FDC in High Risk Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
Conditions: Hypercholesterolemia;   Dyslipidemia
Interventions: Drug: Rosuvastatin + Ezetimibe;   Drug: Simvastatin + Ezetimibe
2 Recruiting Effect of CER-001 on Plaque Volume in Homozygous Familial Hypercholesterolemia (HoFH) Subjects
Condition: Homozygous Familial Hypercholesterolemia
Intervention: Drug: CER-001
3 Unknown † Trial to Assess the Effects of P-OM3 on LDL-C in Subjects With Primary Hypercholesterolemia
Condition: Primary Hypercholesterolemia
Interventions: Drug: P-OM3;   Drug: Placebo
4 Unknown † Flaxseed Compared With Placebo in Patients With Hypercholesterolemia
Condition: Familial or Severe Hypercholesterolemia
Interventions: Dietary Supplement: flaxseed;   Dietary Supplement: whole wheat flour
5 Recruiting The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository
Condition: Homozygous Familial Hypercholesterolemia
Intervention:
6 Unknown † Evaluation of Chylomicrons Metabolism in Sub-Clinical Atherosclerosis in Patients Whit Heterozigous Familial Hypercholesterolemia (FH) Treated With Statin Plus Ezetimibe
Condition: Heterozigous Familial Hypercholesterolemia
Intervention: Drug: Statins and Ezetimibe
7 Recruiting Cholesterol Lowering Treatment With Psyllium Husks and Isolated Soy Protein in Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: Psyllium husks;   Dietary Supplement: Isolated soy protein;   Dietary Supplement: Isolated whey protein;   Other: Microcrystalline cellulose
8 Not yet recruiting A Safety Study of BMS-852927 in Subjects With Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: BMS-852927;   Drug: Placebo
9 Recruiting A Study of the Safety, Pharmacokinetic Drug Interaction and Efficacy of ETC-1002 and Atorvastatin in Subjects With Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: ETC-1002;   Drug: Placebo
10 Not yet recruiting A Multi-center, Randomized Study in Subjects With Primary Hypercholesterolemia or Mixed Dyslipidemia
Condition: Primary Hypercholesterolemia or Mixed Dyslipidemia
Intervention: Device: AMG 145
11 Recruiting A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Conditions: Hypercholesterolemia;   Coronary Heart Disease
Interventions: Drug: mipomersen sodium 200 mg;   Drug: Placebo;   Drug: mipomersen sodium 70 mg
12 Recruiting A Study of the Effect of Ezetimibe on Glucose Metabolism in Type 2 Diabetics With Hypercholesterolemia (P06541)
Condition: Hypercholesterolemia
Interventions: Drug: Ezetimibe;   Drug: Placebo
13 Recruiting Efficacy and Safety of SAR236553 (REGN727) Versus Ezetimibe on Top of Statin in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY Combo II)
Condition: Hypercholesterolemia
Interventions: Drug: SAR236553 (REGN727);   Drug: matching placebo SAR236553 (REGN727);   Drug: Ezetimibe;   Drug: matching placebo for Ezetimibe
14 Recruiting Efficacy and Safety Evaluation of SAR236553 (REGN727) in Patients With Primary Hypercholesterolemia on Stable Atorvastatin Therapy
Condition: Hypercholesterolemia
Interventions: Drug: alirocumab SAR236553 (REGN727);   Drug: placebo;   Drug: atorvastatin
15 Recruiting Efficacy and Safety of SAR236553 (REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia (ODYSSEY Combo I)
Condition: Hypercholesterolemia
Interventions: Drug: SAR236553 (REGN727);   Other: Placebo
16 Recruiting Study of REGN727 (SAR236553) in Patients With Primary Hypercholesterolemia and Moderate, High, or Very High Cardiovascular (CV) Risk, Who Are Intolerant to Statins (Odyssey Alternative)
Condition: Hypercholesterolemia
Interventions: Drug: REGN727 (SAR236553);   Drug: Active Comparator 1 (ezetimibe);   Drug: Active Comparator 2 (atorvastatin);   Other: Placebo 1 (placebo for ezetimibe atorvastatin);   Other: Placebo 2 [(placebo for REGN727 (SAR236553]
17 Recruiting Long-term Safety and Tolerability of SAR236553 (REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY Long Term)
Condition: Hypercholesterolemia
Interventions: Other: placebo;   Drug: SAR236553 (REGN727)
18 Recruiting Efficacy and Safety of SAR236553 (REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
Condition: Hypercholesterolemia
Interventions: Drug: SAR236553 (REGN727);   Other: placebo
19 Recruiting Trial Evaluating PCSK9 Antibody in Subjects With LDL Receptor Abnormalities
Condition: Homozygous Familial Hypercholesterolemia
Interventions: Biological: AMG 145;   Other: Placebo
20 Recruiting Study of REGN727 (SAR236553) in Patients With heFH (Heterozygous Familial Hypercholesterolemia) Who Are Not Adequately Controlled With Their LMT (Lipid-Modifying Therapy)
Condition: Heterozygous Familial Hypercholesterolemia
Interventions: Drug: LMT (atorvastatin, simvastatin, or rosuvastatin);   Drug: REGN727 (SAR236553);   Other: Placebo
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years